[1]
R. K. Ibrahim and R. Y. Al-Hamdani, “Comparative Effects of Repaglinide Versus Glibenclamide on Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients”, Tikrit J. Pharm. Sci., vol. 8, no. 1, pp. 22–28, Apr. 2023.